| Literature DB >> 31051266 |
Maria Abedin Zadeh1, Mouhamad Khoder2, Ali A Al-Kinani1, Husam M Younes3, Raid G Alany4.
Abstract
Degenerative retinal diseases, such as age-related macular degeneration (AMD), can lead to permanent sight loss. Although intravitreal anti-vascular endothelial growth factor (VEGF) and steroid injections are effective for the management of early stages of wet and/or neovascular AMD (nAMD), no proven treatments currently exist for dry AMD or for the advanced geographic atrophy of the retina that follows. Tissue engineering (TE) has recently emerged as a promising alternative to repair retinal damaged and restore its functions. Here, we review recent advances in TE, with a particular emphasis on retinal regeneration. We provide an overview of retinal diseases, followed by a comprehensive review of TE techniques, cells, and polymers used in the fabrication of scaffolds for retinal cell regenerations, in particular the retinal pigment epithelium (RPE). CrownEntities:
Mesh:
Substances:
Year: 2019 PMID: 31051266 DOI: 10.1016/j.drudis.2019.04.009
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851